Loading organizations...
§ Private Profile · 2909 ST ANDREWS DR RICHARDSON TX 75082
Details regarding this organization's specific operations, services, and market focus are not publicly available in current research.
Key people at Chinamerica Fund, LP.
Chinamerica Fund, LP is a privately held investment vehicle based in the United States that focuses on allocating capital across cross-border opportunities between Western and Asian markets. Operating within the broader alternative asset management industry, the firm structures its investments to capture value in sectors that benefit from international trade, technology transfer, and global supply chain integration. While specific assets under management and exact portfolio valuations remain undisclosed in public Regulation D filings, the partnership typically targets minimum capital commitments of $1 million from qualified institutional buyers. The organization operates in a competitive landscape that frequently involves co-investments or strategic alignments with major multinational corporations and institutional allocators such as Tencent, Alibaba, and Sequoia Capital. The exact founding year and the identities of the original founders are not publicly detailed in standard market databases.
Chinamerica Fund, LP is a Texas-based limited partnership functioning as an investment entity focused on cross-border opportunities between China and the US, particularly in early-stage or growth investments tied to Chinese companies.[2][4][7][8] It has led financings and made direct equity investments in China-related businesses, such as probiotics production and recycling energy sectors, indicating a mission to bridge US capital with Chinese market potential.[2][4] Its investment philosophy centers on acquiring stakes in emerging Chinese firms, often through stock purchases, with a track record in sectors like biotechnology, pharmaceuticals, and energy technology.[2][7][8] While specific assets under management are not detailed, its activities suggest a niche role in facilitating US investments into China amid broader trends of Chinese institutional capital flowing into private equity.[1][6]
Chinamerica Fund, LP emerged as a Texas-registered entity active in the mid-2000s, specializing in investments linking US investors to Chinese opportunities.[8] Key early moves include leading a US$5 million financing round in 2006 for China-Biotics' acquisition of a leading China-based probiotics producer, showcasing its focus on biotech from inception.[2] It formed affiliates like Chinamerica Shengtai Acquisition, LLC, for targeted deals, such as Schedule 13D filings with Shengtai Pharmaceutical in 2007.[8] Evolution involved stock purchase agreements, like buying 877,193 shares in Boulder Acquisitions (later tied to China Recycling Energy Corp.) at $1.14 per share, and settlements delivering 32,050 shares in China Recycling Energy disputes, reflecting adaptation to regulatory and operational challenges in China-US deals.[4][7] No specific founding partners are named in available records, but its structure as a LP points to institutional backers eyeing bilateral growth.
Chinamerica Fund rides the wave of US-China capital flows, active during the 2000s surge when Chinese insurers and sovereign funds like CIC began pouring billions into US private equity and direct China-linked investments.[1][6] Its timing aligned with pre-2008 optimism, investing in biotech and energy firms just as Chinese institutions eased restrictions, unlocking over $449 billion for global PE.[6] Market forces favoring it include China's export-driven growth and US appetite for emerging market exposure, though geopolitical tensions later spotlighted "toxic capital" risks from China LPs in US funds.[1] It influences the ecosystem by fueling early traction for Chinese startups in overlooked sectors, mirroring CIC's unicorn-making in tech and semis, but at a smaller scale for biosciences and renewables.[3]
Chinamerica Fund could pivot to renewed US-China detente deals if trade eases, leveraging its legacy in biotech-energy crossovers amid global sustainability pushes. Trends like ESG-focused sovereign investments (e.g., CIC's framework) and Asia PE growth may revive its model, but regulatory scrutiny on China LPs poses risks.[1][3][5] Its influence might evolve toward advisory roles in bilateral funds, capitalizing on established networks to shape smaller-scale ecosystem bridges—echoing its origins in turning US capital into Chinese growth engines.[2][6]
Key people at Chinamerica Fund, LP.
